PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
Trial ID or NCT#
The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.
Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients
Contact us to find out if this trial is right for you.
Martina Kelly Speight